Immune-gene therapy can be advantageously performed with nonviral approache
s. Genes that encode regulatory cytokines or inflammatory cytokine inhibito
rs can be delivered intramuscularly and expressed for weeks or months. This
type of gene transfer into muscle has been shown to ameliorate several aut
oimmune diseases and is relevant to the development of effective DNA vaccin
es in autoimmune diseases, infectious diseases and cancer.